Tue, Apr
9 New Articles

Almac Clinical Technologies, part of the Almac Group, the world’s largest privately-held contract pharmaceutical development and manufacturing organisation announced the formation of a strategic partnership with inVentiv Health, a leading biopharma outsourcing company combining a leading CRO and the industry’s only Contract Commercial Organization (CCO).

ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders,announced the start of two phase III studies designed to evaluate an investigational long-acting,injectable regimen of cabotegravir (ViiV Healthcare) and rilpivirine (Janssen Sciences Ireland UC) for the treatment of HIV-1 infection.

More Articles ...